nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00569	0.00569	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00555	0.00555	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00553	0.00553	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00522	0.00522	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.0052	0.0052	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00511	0.00511	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00511	0.00511	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TPK1—amyotrophic lateral sclerosis	0.00471	0.00471	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0047	0.0047	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00468	0.00468	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00442	0.00442	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00438	0.00438	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00438	0.00438	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00435	0.00435	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00433	0.00433	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00428	0.00428	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00414	0.00414	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00412	0.00412	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00411	0.00411	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.00411	0.00411	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00409	0.00409	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00407	0.00407	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00401	0.00401	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00394	0.00394	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00394	0.00394	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00392	0.00392	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—VTA1—amyotrophic lateral sclerosis	0.00376	0.00376	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00375	0.00375	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00373	0.00373	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00369	0.00369	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00363	0.00363	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00361	0.00361	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00358	0.00358	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00354	0.00354	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.0035	0.0035	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.0035	0.0035	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00343	0.00343	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00335	0.00335	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00329	0.00329	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00326	0.00326	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00319	0.00319	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00315	0.00315	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00312	0.00312	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00306	0.00306	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00303	0.00303	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.00301	0.00301	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00299	0.00299	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00295	0.00295	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00291	0.00291	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00291	0.00291	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00285	0.00285	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—DAO—amyotrophic lateral sclerosis	0.00285	0.00285	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00285	0.00285	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0028	0.0028	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00279	0.00279	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	0.00272	0.00272	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00271	0.00271	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00269	0.00269	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00268	0.00268	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00266	0.00266	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.00266	0.00266	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PLB1—amyotrophic lateral sclerosis	0.00258	0.00258	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00258	0.00258	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00258	0.00258	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.00256	0.00256	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00255	0.00255	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00247	0.00247	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00242	0.00242	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00242	0.00242	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.00242	0.00242	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.0024	0.0024	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00238	0.00238	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00237	0.00237	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00232	0.00232	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—VCP—amyotrophic lateral sclerosis	0.0023	0.0023	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.0023	0.0023	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00228	0.00228	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00228	0.00228	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00227	0.00227	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00226	0.00226	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00223	0.00223	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	0.00217	0.00217	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00216	0.00216	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00216	0.00216	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.00214	0.00214	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00212	0.00212	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0021	0.0021	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—DAO—amyotrophic lateral sclerosis	0.0021	0.0021	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00208	0.00208	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00208	0.00208	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00204	0.00204	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00204	0.00204	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00204	0.00204	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00202	0.00202	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00202	0.00202	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	0.00199	0.00199	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00195	0.00195	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00194	0.00194	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00193	0.00193	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00192	0.00192	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00192	0.00192	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00189	0.00189	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00184	0.00184	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00182	0.00182	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00182	0.00182	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00182	0.00182	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00182	0.00182	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.0018	0.0018	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00175	0.00175	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	0.00165	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00165	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00165	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00164	0.00164	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00162	0.00162	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.0016	0.0016	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00159	0.00159	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00154	0.00154	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00153	0.00153	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	0.00149	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00149	0.00149	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GSR—amyotrophic lateral sclerosis	0.00147	0.00147	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00147	0.00147	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00147	0.00147	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00138	0.00138	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00134	0.00134	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00134	0.00134	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	0.00133	0.00133	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00132	0.00132	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.0013	0.0013	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.00127	0.00127	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00125	0.00125	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00125	0.00125	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00125	0.00125	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00125	0.00125	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00124	0.00124	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00124	0.00124	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00124	0.00124	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00121	0.00121	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	0.0012	0.0012	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.0012	0.0012	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00119	0.00119	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00117	0.00117	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00116	0.00116	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00115	0.00115	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00114	0.00114	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00113	0.00113	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.0011	0.0011	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00108	0.00108	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00108	0.00108	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.00108	0.00108	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	0.00106	0.00106	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00106	0.00106	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00105	0.00105	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	0.00103	0.00103	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00101	0.00101	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00101	0.00101	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000994	0.000994	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000991	0.000991	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000961	0.000961	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000961	0.000961	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	0.000953	0.000953	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000946	0.000946	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000944	0.000944	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.00094	0.00094	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000926	0.000926	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000921	0.000921	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000899	0.000899	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00088	0.00088	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000871	0.000871	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000866	0.000866	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000863	0.000863	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000861	0.000861	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000859	0.000859	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000856	0.000856	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000812	0.000812	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000809	0.000809	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000809	0.000809	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000805	0.000805	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	0.000794	0.000794	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000783	0.000783	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000755	0.000755	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000743	0.000743	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000732	0.000732	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	0.000693	0.000693	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000682	0.000682	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000674	0.000674	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000668	0.000668	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000668	0.000668	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	0.000665	0.000665	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000649	0.000649	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000629	0.000629	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000625	0.000625	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000614	0.000614	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000611	0.000611	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00061	0.00061	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000596	0.000596	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000594	0.000594	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000593	0.000593	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000591	0.000591	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000573	0.000573	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000568	0.000568	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000555	0.000555	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000548	0.000548	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	0.000544	0.000544	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000534	0.000534	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000531	0.000531	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000517	0.000517	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000512	0.000512	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000508	0.000508	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000491	0.000491	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000483	0.000483	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000471	0.000471	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000467	0.000467	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000466	0.000466	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000464	0.000464	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	0.000459	0.000459	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000456	0.000456	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00045	0.00045	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00042	0.00042	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000401	0.000401	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000384	0.000384	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000384	0.000384	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000366	0.000366	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000338	0.000338	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000336	0.000336	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000328	0.000328	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000323	0.000323	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	0.000314	0.000314	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000301	0.000301	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000278	0.000278	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000277	0.000277	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000263	0.000263	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000263	0.000263	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000255	0.000255	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	0.000248	0.000248	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000242	0.000242	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000226	0.000226	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000222	0.000222	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	0.00021	0.00021	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000208	0.000208	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000183	0.000183	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	0.000171	0.000171	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.00017	0.00017	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000149	0.000149	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000144	0.000144	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.000137	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000125	0.000125	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000117	0.000117	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000113	0.000113	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.72e-05	7.72e-05	CbGpPWpGaD
